Bin-yong Liang

α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas

Eswari Dodagatta-Marri, Dominique S. Meyer, Melissa Quino Reeves et al. · Journal for ImmunoTherapy of Cancer · 2019 · 166 citations · Full text

Long-Term Outcomes of Repeat Hepatic Resection in Patients with Recurrent Hepatocellular Carcinoma and Analysis of Recurrent Types and Their Prognosis: A Single-Center Experience in China

Zhiyong Huang, Bin-yong Liang, Min Xiong et al. · Annals of Surgical Oncology · 2012 · 113 citations

Recurrent Types, Surgical Oncology, Hepatology +12

Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma

Runze Shang, Xinhua Song, Pan Wang et al. · Gut · 2020 · 105 citations · Full text

Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation

Xinhua Song, Hongwei Xu, Pan Wang et al. · Journal of Hepatology · 2021 · 98 citations · Full text

Cancer Research, Focal Adhesion Kinase, Signaling Pathway +10

TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis

Bin-yong Liang, Yi Zhou, Manning Qian et al. · Journal of Hepatology · 2021 · 56 citations · Full text